More Zelira Therapeutics Ltd. news
Zelira Therapeutics Ltd.ASX: ZLD

Cantor Fitzgerald - Investor Presentation

Jun 30, 2021 at 12:06 AM EDT · Issued by Zelira Therapeutics Ltd.

Filed with ASX · Jun 30, 2021 at 12:06 AM EDT

On 6ix: 6ix.com/news/cantor-fitzgerald-investor-presentation

Zelira Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Zelira Therapeutics Ltd. on 6ix

In the deck

  • Zelira Therapeutics — Investor Presentation (June 2021)17 slidesJun 30, 2021

Earlier from Zelira Therapeutics

  • Research Demonstrates Significant Uptake of CBD Into BrainJun 18, 2021
  • Zelira to Launch CBD Toothpaste in the United KingdomJun 14, 2021
  • ZLD and Levin Health to Conduct Chronic Pain Clinical TrialJun 2, 2021
  • Zeliras HOPE Range of Products Launches in Washington DCMay 5, 2021
  • March 2021 Quarterly ReportApr 21, 2021

Later from Zelira Therapeutics

  • US Observational Clinical Pain Trial Receives IRB ApprovalJul 11, 2021
  • June 2021 Quarterly Activities ReportJul 29, 2021
  • Appendix 4C - quarterlyJul 29, 2021
  • Zelira enters Germany via Exclusive Distribution AgreementSep 19, 2021
  • Zelira Launches RAF FIVE Acne Treatment ProductsSep 22, 2021
All Zelira Therapeutics news releases↗

Follow Zelira Therapeutics into a list and get an email when it puts out news.

Follow Zelira Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer